Hydroxychloroquine and azithromycin alter the contractility of living porcine heart slices

The cardiotoxicity risk of hydroxychloroquine (HCQ) and azithromycin (AZM) has been the subject of intensive research triggered by safety concerns in COVID-19 patients. HCQ and AZM have been associated with QT interval prolongation and drug-induced arrhythmias, however other cardiotoxicity mechanism...

Full description

Bibliographic Details
Main Authors: Qin Wu, Abigail J. Ross, Tugce Ipek, Georgina H. Thompson, Robert D. Johnson, Changhao Wu, Patrizia Camelliti
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-05-01
Series:Frontiers in Pharmacology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fphar.2023.1127388/full
_version_ 1797833063356432384
author Qin Wu
Qin Wu
Abigail J. Ross
Tugce Ipek
Georgina H. Thompson
Robert D. Johnson
Changhao Wu
Patrizia Camelliti
author_facet Qin Wu
Qin Wu
Abigail J. Ross
Tugce Ipek
Georgina H. Thompson
Robert D. Johnson
Changhao Wu
Patrizia Camelliti
author_sort Qin Wu
collection DOAJ
description The cardiotoxicity risk of hydroxychloroquine (HCQ) and azithromycin (AZM) has been the subject of intensive research triggered by safety concerns in COVID-19 patients. HCQ and AZM have been associated with QT interval prolongation and drug-induced arrhythmias, however other cardiotoxicity mechanisms remain largely unexplored. Our group has pioneered the living heart slice preparation, an ex-vivo platform that maintains native cardiac tissue architecture and physiological electrical and contractile properties. Here, we evaluated the cardiotoxic effect of HCQ and AZM applied alone or in combination on cardiac contractility by measuring contractile force and contraction kinetics in heart slices prepared from porcine hearts. Our results show that clinically relevant concentrations of HCQ monotherapy (1–10 µM) reduced contractile force and contraction kinetics in porcine slices in a dose-dependent manner. However, AZM monotherapy decreased contractile force and contraction kinetics only at higher concentrations (30 µM). Combination of HCQ and AZM induced a dose-dependent effect similar to HCQ alone. Furthermore, pre-treating porcine heart slices with the L-type calcium channel agonist Bay K8644 prevented the effect of both drugs, while administration of Bay K8644 after drugs interventions largely reversed the effects, suggesting a mechanism involving inhibition of L-type calcium channels. These findings indicate that HCQ and AZM alter cardiac function beyond QT prolongation with significant contractile dysfunction in intact cardiac tissue. Our porcine heart slices provide a powerful platform to investigate mechanisms of drug cardiotoxicity.
first_indexed 2024-04-09T14:17:43Z
format Article
id doaj.art-b6da9934a8844a17b964cae91e0b70e9
institution Directory Open Access Journal
issn 1663-9812
language English
last_indexed 2024-04-09T14:17:43Z
publishDate 2023-05-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Pharmacology
spelling doaj.art-b6da9934a8844a17b964cae91e0b70e92023-05-05T05:59:25ZengFrontiers Media S.A.Frontiers in Pharmacology1663-98122023-05-011410.3389/fphar.2023.11273881127388Hydroxychloroquine and azithromycin alter the contractility of living porcine heart slicesQin Wu0Qin Wu1Abigail J. Ross2Tugce Ipek3Georgina H. Thompson4Robert D. Johnson5Changhao Wu6Patrizia Camelliti7School of Medicine, Jiangsu Vocational College of Medicine, Yancheng, ChinaSchool of Biosciences and Medicine, University of Surrey, Guildford, United KingdomSchool of Biosciences and Medicine, University of Surrey, Guildford, United KingdomSchool of Biosciences and Medicine, University of Surrey, Guildford, United KingdomSchool of Biosciences and Medicine, University of Surrey, Guildford, United KingdomSchool of Biosciences and Medicine, University of Surrey, Guildford, United KingdomSchool of Biosciences and Medicine, University of Surrey, Guildford, United KingdomSchool of Biosciences and Medicine, University of Surrey, Guildford, United KingdomThe cardiotoxicity risk of hydroxychloroquine (HCQ) and azithromycin (AZM) has been the subject of intensive research triggered by safety concerns in COVID-19 patients. HCQ and AZM have been associated with QT interval prolongation and drug-induced arrhythmias, however other cardiotoxicity mechanisms remain largely unexplored. Our group has pioneered the living heart slice preparation, an ex-vivo platform that maintains native cardiac tissue architecture and physiological electrical and contractile properties. Here, we evaluated the cardiotoxic effect of HCQ and AZM applied alone or in combination on cardiac contractility by measuring contractile force and contraction kinetics in heart slices prepared from porcine hearts. Our results show that clinically relevant concentrations of HCQ monotherapy (1–10 µM) reduced contractile force and contraction kinetics in porcine slices in a dose-dependent manner. However, AZM monotherapy decreased contractile force and contraction kinetics only at higher concentrations (30 µM). Combination of HCQ and AZM induced a dose-dependent effect similar to HCQ alone. Furthermore, pre-treating porcine heart slices with the L-type calcium channel agonist Bay K8644 prevented the effect of both drugs, while administration of Bay K8644 after drugs interventions largely reversed the effects, suggesting a mechanism involving inhibition of L-type calcium channels. These findings indicate that HCQ and AZM alter cardiac function beyond QT prolongation with significant contractile dysfunction in intact cardiac tissue. Our porcine heart slices provide a powerful platform to investigate mechanisms of drug cardiotoxicity.https://www.frontiersin.org/articles/10.3389/fphar.2023.1127388/fullmyocardial slicesorganotypic ex-vivo modelsCOVID-19cardiotoxicitysafety pharmacologycalcium channels
spellingShingle Qin Wu
Qin Wu
Abigail J. Ross
Tugce Ipek
Georgina H. Thompson
Robert D. Johnson
Changhao Wu
Patrizia Camelliti
Hydroxychloroquine and azithromycin alter the contractility of living porcine heart slices
Frontiers in Pharmacology
myocardial slices
organotypic ex-vivo models
COVID-19
cardiotoxicity
safety pharmacology
calcium channels
title Hydroxychloroquine and azithromycin alter the contractility of living porcine heart slices
title_full Hydroxychloroquine and azithromycin alter the contractility of living porcine heart slices
title_fullStr Hydroxychloroquine and azithromycin alter the contractility of living porcine heart slices
title_full_unstemmed Hydroxychloroquine and azithromycin alter the contractility of living porcine heart slices
title_short Hydroxychloroquine and azithromycin alter the contractility of living porcine heart slices
title_sort hydroxychloroquine and azithromycin alter the contractility of living porcine heart slices
topic myocardial slices
organotypic ex-vivo models
COVID-19
cardiotoxicity
safety pharmacology
calcium channels
url https://www.frontiersin.org/articles/10.3389/fphar.2023.1127388/full
work_keys_str_mv AT qinwu hydroxychloroquineandazithromycinalterthecontractilityoflivingporcineheartslices
AT qinwu hydroxychloroquineandazithromycinalterthecontractilityoflivingporcineheartslices
AT abigailjross hydroxychloroquineandazithromycinalterthecontractilityoflivingporcineheartslices
AT tugceipek hydroxychloroquineandazithromycinalterthecontractilityoflivingporcineheartslices
AT georginahthompson hydroxychloroquineandazithromycinalterthecontractilityoflivingporcineheartslices
AT robertdjohnson hydroxychloroquineandazithromycinalterthecontractilityoflivingporcineheartslices
AT changhaowu hydroxychloroquineandazithromycinalterthecontractilityoflivingporcineheartslices
AT patriziacamelliti hydroxychloroquineandazithromycinalterthecontractilityoflivingporcineheartslices